Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)

Annals of Surgery

Volumn 265, Issue 5, 2017, Pages 882-888

  Ansari, Nabila ^a   Solomon, Michael J ^a   Fisher, Richard J ^b   MacKay, John ^b   Burmeister, Bryan ^c   Ackland, Stephen ^d   Heriot, Alexander ^b   Joseph, David ^e   McLachlan, Sue Anne ^f,g   McClure, Bev ^b   Ngan, Samuel Y ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

acute adverse events; long course chemoradiotherapy; rectal cancer; short course radiotherapy; surgical complications

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ABDOMINAL INJURY; ABDOMINAL PAIN; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALOPECIA; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHEMORADIOTHERAPY; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEFECATION DISORDER; DEHYDRATION; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DYSURIA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; FOLLOW UP; FUNGEMIA; HAND FOOT SYNDROME; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMATURIA; HEMORRHOID; HUMAN; INTESTINE OBSTRUCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUROPATHIC PAIN; OVERALL SURVIVAL; PANCYTOPENIA; PELVIS ABSCESS; PERINEAL PAIN; PHARYNGITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE ILEUS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTITIS; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INDUCED EMESIS; RADIATION SICKNESS; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; RECURRENCE FREE SURVIVAL; SEPTICEMIA; STOMATITIS; SURGICAL MORTALITY; URINARY URGENCY; URINE RETENTION; WOUND COMPLICATION; ADENOCARCINOMA; ADJUVANT RADIOTHERAPY; ADVERSE EFFECTS; CANCER STAGING; CAUSE OF DEATH; CLINICAL TRIAL; COLON RESECTION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEOADJUVANT THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RADIATION RESPONSE; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TASMANIA; TIME FACTOR; TREATMENT OUTCOME; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGED; CAUSE OF DEATH; CHEMORADIOTHERAPY; COLECTOMY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TASMANIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84987863683     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001987     Document Type: Article

References (19)

1. Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA. 2000;284:1008-1015.
2. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet. 2001;358:1291-1304.
3. Kapitejin E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
4. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
5. Glimelius B, Gronberg H, Jarhult J, et al. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncologica. 2003;42:476-492.
6. Marijnen CA, Kapitejin E, Van de Velde CJ, et al. Acute side effects and complications after short-course preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicentre randomized trial. J Clin Oncol. 2002;20:817-825.
7. Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancer: results of FFCD 9203. J Clin Oncol. 2006;24:4620-4625.
8. Bosset JF, Calais G, Daban A, et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer. 2004;40:219-224.
9. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long term results of a randomised trial comparing preoperative short-course radiotherapy with pre-operative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93:1215-1223.
10. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preser-vation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated chemoradiation for rectal cancer. Radiother Oncol. 2004;72:15-24.
11. Ngan SY, Burmeister B, Fisher R, et al. Randomised trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. J Clin Oncol. 2012;30: 3827-3833.
12. Clinical Oncological Society of Australia and Australian Cancer Network. Elective surgery for rectal cancer, in NHMRC Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Commonwealth of Australia, 2005, 135-142, 159-165. Available at: https://www.nhmrc.gov.au/-files-nhmrc/publications/attachments/cp106-clini cal-practice-guidelines-prevention-early-detection-management-of- colorectal-cancer-150609-0.pdf. Accessed August, 2016.
13. National Cancer Institute. Cancer Therapy Evaluation Program. Common Toxicity Criteria Manual 1. Version 2, June 1, 1999. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcma nual-v4-10-4-99.pdf. Accessed August, 2016.
14. Barnard GA. A new test for 2 x 2 tables. Nature. 1945;156:177.
15. McLachlan SA, Fisher RJ, Zalcberg J, et al. The impact of health-related quality of life in the first 12 months: a randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.01). Eur J Cancer. 2016;55:15-26.
16. Frykholm GJ, Sintorn K, Montelius A, et al. Acute lumbosacral plexopathy during and after pre-operative radiotherapy of rectal adenocarcinoma. Radio-ther Oncol. 1996;38:121-130.
17. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTGC016): a multicentre, randomised trial. Lancet. 2009;373:811-820.
18. Jabbour SK, Patel S, Herman J, et al. Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits. Int J Surg Oncol. 2012;2012:891067.
19. Wang L, Li ZY, Li SW, et al. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer. Dis Colon Rectum. 2015;58:186-192.